(IMAGE)

KU Leuven

Caption

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue. The teams collaborated closely with Janssen Pharmaceutica, N.V. The antiviral molecule is exceptionally effective against all known dengue variants and could be used for therapeutic and prevention purposes.

Credit

KU Leuven - Rob Stevens

Usage Restrictions

This image may only be used with appropriate credit and in relation to the press release "KU Leuven develops very potent antiviral against dengue", issued on 4 October 2021.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.